Gosset Ownership
Private
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Nano PharmaSolutions General Information
Nano PharmaSolutions has developed a proprietary, chemical-free nanoformulation platform that increases the solubility and bioavailability of poorly soluble small molecule drugs. The company collaborates with pharma partners to apply its technology to both approved and investigational compounds. No clinical results reported as the focus is on enabling technologies rather than direct drug development.
Contact Information
Primary Industry
Drug Discovery Services
Corporate Office
San Diego, California
United States
United States
Drug Pipeline
NT-301
Pre-clinicalKey Partnerships
Mikart LLC (CDMO collaboration for installation of NanoTransformer™ at Atlanta facility)
Nano PharmaSolutions Funding
No funding data available
To view Nano PharmaSolutions's complete valuation and funding history, request access »